139 related articles for article (PubMed ID: 38206110)
1. Utilizing PTEN immunohistochemistry as a screening test for Cowden syndrome.
Hartsough E; DeSimone MS; Lorenzo ME; Dias-Santagata D; Nose V; Hoang MP
Am J Clin Pathol; 2024 May; 161(5):490-500. PubMed ID: 38206110
[TBL] [Abstract][Full Text] [Related]
2. Phosphatase and tensin homolog immunohistochemical staining and clinical criteria for Cowden syndrome in patients with trichilemmoma or associated lesions.
Jin M; Hampel H; Pilarski R; Zhou X; Peters S; Frankel WL
Am J Dermatopathol; 2013 Aug; 35(6):637-40. PubMed ID: 23715080
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical staining of thyroidectomy specimens for PTEN can aid in the identification of patients with Cowden syndrome.
Barletta JA; Bellizzi AM; Hornick JL
Am J Surg Pathol; 2011 Oct; 35(10):1505-11. PubMed ID: 21921783
[TBL] [Abstract][Full Text] [Related]
4. Thyroid Follicular Cell-derived Carcinomas in a Background of Multiple Adenomatous Nodules Leading to a Diagnosis of
Liu A; Borges PM; Tay YS; Thompson LDR; Kong MX; Lai J
Anticancer Res; 2022 Mar; 42(3):1481-1485. PubMed ID: 35220242
[TBL] [Abstract][Full Text] [Related]
5. Utility of PTEN protein dosage in predicting for underlying germline PTEN mutations among patients presenting with thyroid cancer and Cowden-like phenotypes.
Ngeow J; He X; Mester JL; Lei J; Romigh T; Orloff MS; Milas M; Eng C
J Clin Endocrinol Metab; 2012 Dec; 97(12):E2320-7. PubMed ID: 23066114
[TBL] [Abstract][Full Text] [Related]
6. Genodermatosis Affecting the Skin and Mucosa of the Head and Neck: Clinicopathologic, Genetic, and Molecular Aspect--PTEN-Hamartoma Tumor Syndrome/Cowden Syndrome.
Nosé V
Head Neck Pathol; 2016 Jun; 10(2):131-8. PubMed ID: 26975628
[TBL] [Abstract][Full Text] [Related]
7. Trichilemmomas show loss of PTEN in Cowden syndrome but only rarely in sporadic tumors.
Al-Zaid T; Ditelberg JS; Prieto VG; Lev D; Luthra R; Davies MA; Diwan AH; Wang WL; Lazar AJ
J Cutan Pathol; 2012 May; 39(5):493-9. PubMed ID: 22486434
[TBL] [Abstract][Full Text] [Related]
8. New mutation in the PTEN gene in a Brazilian patient with Cowden's syndrome.
Lima EU; Soares IC; Danilovic DL; Marui S
Arq Bras Endocrinol Metabol; 2012 Nov; 56(8):592-6. PubMed ID: 23295304
[TBL] [Abstract][Full Text] [Related]
9. PTEN lipid phosphatase activity and proper subcellular localization are necessary and sufficient for down-regulating AKT phosphorylation in the nucleus in Cowden syndrome.
He X; Saji M; Radhakrishnan D; Romigh T; Ngeow J; Yu Q; Wang Y; Ringel MD; Eng C
J Clin Endocrinol Metab; 2012 Nov; 97(11):E2179-87. PubMed ID: 22962422
[TBL] [Abstract][Full Text] [Related]
10. Cowden syndrome presenting with trichilemmomas.
Ng E; Terushkin V; Meehan SA; Ho R; Pomeranz MK
Dermatol Online J; 2016 Dec; 22(12):. PubMed ID: 28329541
[TBL] [Abstract][Full Text] [Related]
11. Cowden syndrome: report of two cases with immunohistochemical analysis for PTEN expression.
Zabetian S; Mehregan D
Am J Dermatopathol; 2012 Aug; 34(6):632-4. PubMed ID: 22481496
[TBL] [Abstract][Full Text] [Related]
12. Male breast cancer in Cowden syndrome patients with germline PTEN mutations.
Fackenthal JD; Marsh DJ; Richardson AL; Cummings SA; Eng C; Robinson BG; Olopade OI
J Med Genet; 2001 Mar; 38(3):159-64. PubMed ID: 11238682
[TBL] [Abstract][Full Text] [Related]
13. Incidence and clinical characteristics of thyroid cancer in prospective series of individuals with Cowden and Cowden-like syndrome characterized by germline PTEN, SDH, or KLLN alterations.
Ngeow J; Mester J; Rybicki LA; Ni Y; Milas M; Eng C
J Clin Endocrinol Metab; 2011 Dec; 96(12):E2063-71. PubMed ID: 21956414
[TBL] [Abstract][Full Text] [Related]
14. Breast cancer risk and clinical implications for germline PTEN mutation carriers.
Ngeow J; Sesock K; Eng C
Breast Cancer Res Treat; 2017 Aug; 165(1):1-8. PubMed ID: 26700035
[TBL] [Abstract][Full Text] [Related]
15. Multiple sclerotic fibromas of the skin: an important clue for the diagnosis of Cowden syndrome.
Kieselova K; Santiago F; Henrique M; Cunha MF
BMJ Case Rep; 2017 Aug; 2017():. PubMed ID: 28847996
[TBL] [Abstract][Full Text] [Related]
16. [Cowden syndrome, or multiple hamartomatous tumor syndrome, in clinical endocrinology].
Sardinoux M; Raingeard I; Bessis D; Coupier I; Renard E; Bringer J
Ann Endocrinol (Paris); 2010 Sep; 71(4):264-73. PubMed ID: 20627233
[TBL] [Abstract][Full Text] [Related]
17. Ovarian Clear Cell Carcinoma in Cowden Syndrome.
Yauy K; Imbert-Bouteille M; Bubien V; Lindet-Bourgeois C; Rathat G; Perrochia H; MacGrogan G; Longy M; Bessis D; Tinat J; Baert-Desurmont S; Blanluet M; Perre PV; Baudry K; Pujol P; Corsini C
J Natl Compr Canc Netw; 2019 Jan; 17(1):7-11. PubMed ID: 30659124
[TBL] [Abstract][Full Text] [Related]
18. Germline mutations and variants in the succinate dehydrogenase genes in Cowden and Cowden-like syndromes.
Ni Y; Zbuk KM; Sadler T; Patocs A; Lobo G; Edelman E; Platzer P; Orloff MS; Waite KA; Eng C
Am J Hum Genet; 2008 Aug; 83(2):261-8. PubMed ID: 18678321
[TBL] [Abstract][Full Text] [Related]
19. Germline SDHx variants modify breast and thyroid cancer risks in Cowden and Cowden-like syndrome via FAD/NAD-dependant destabilization of p53.
Ni Y; He X; Chen J; Moline J; Mester J; Orloff MS; Ringel MD; Eng C
Hum Mol Genet; 2012 Jan; 21(2):300-10. PubMed ID: 21979946
[TBL] [Abstract][Full Text] [Related]
20. KLLN epigenotype-phenotype associations in Cowden syndrome.
Nizialek EA; Mester JL; Dhiman VK; Smiraglia DJ; Eng C
Eur J Hum Genet; 2015 Nov; 23(11):1538-43. PubMed ID: 25669429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
